ArticleHarm reduction journal2021

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.

Heather Palis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.